Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
A Single Site, Phase 2B, Randomized, Double-Blind, Study to Assess the Efficacy, Safety, and Tolerability of Low-Dose Naltrexone and Acetaminophen Combination vs. Placebo in the Treatment of Chronic Low Back Pain (ANODYNE-4)
Sponsor: Allodynic Therapeutics, Inc
This PHASE2 trial investigates Chronic Low Back Pain and Lumbar Radiculopathy and is currently completed. Allodynic Therapeutics, Inc leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Completed PHASE2
-
May 2021 — Jan 2024 [monthly]
Completed PHASE2
Phase: PHASE2_PHASE3 → PHASE2
-
Jan 2021 — May 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 7 earlier versions
-
Jul 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Jun 2018 — Jul 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Nov 2017 — May 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2017 — Nov 2017 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jul 2017 — Aug 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Allodynic Therapeutics, Inc
For direct contact, visit the study record on ClinicalTrials.gov .